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I read the article by Brzozowski et al. about the per-
centage of intracranial haemorrhage in type I dural ar-
teriovenous fistula with great interest [1]. In the paper, 
the authors demonstrated that 50% of patients with dural 
arteriovenous fistula presented with intracranial haem-
orrhage. However, the results of the paper were not con-
cordant with the already published data in some larger 
studies (n = 236-1075), which have demonstrated a risk 
of intracranial haemorrhage between 12% and 23.7% 
[2-5] (Table 1). In the paper published by Li et al., only 
two cases out of the reported 91 with Borden type I (Cog-
nard type I and type IIa) dural arteriovenous fistulas pre-
sented with an intracranial haemorrhage, as compared 
to 28.6% in the authors’ paper. The sample size of the 
study and the inclusion of only those patients who were 
managed with embolisation probably contributed to this 
discrepancy.
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Table 1. Review of literature on the presence of intracranial haemorrhage 
in patients with dural arteriovenous fistula
Paper Number 
of patients 
% of patients
 presenting 
with 
haemorrhage
% of patients 
presenting with 
haemorrhage  
in Cognard type 1 
dural arteriovenous 
fistula
Li et al. 236 23.7% (n = 56) 3.6% (n = 2)
Hiramatsu et al. 1075 12.0% (n = 129) –
Piippo et al. 261 13.0% (n = 34) –
Singh et al. 402 18.0% (n = 72) –
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